Session Description
Dr. Taxiarchis Kourelis will deliver a case-based presentation of “How I Treat” myeloma and plasma cell dyscrasia. He will present a comprehensive review of the efficacy of quadruplet therapy for patients with high-risk MM. The presentation will include a review of the optimal duration of lenalidomide maintenance after ASCT and the potential to assess MD from a peripheral blood sample. Additionally, the session will review the outcomes of non-Caucasian patients undergoing CAR-T cell therapy and the outcomes and management of patients progressing after CAR-T cell therapies. Lastly, the Dr. Kourelis will review the future developments anticipated in MM bispecific antibody therapies.